

Aclarion, Inc. (NASDAQ: ACON) closed a $10.4 million financing at $5.18/share, boosting balance sheet & extending cash runway to 2028.
You can purchase shares of Aclarion (NASDAQ:ACON) through any online brokerage.
Other companies in Aclarion’s space includes: Veeva Systems Inc (NYSE:VEEV), Doximity Inc (NYSE:DOCS), Waystar Holding Corp (NASDAQ:WAY), HeartFlow Inc (NASDAQ:HTFL) and Schrodinger Inc (NASDAQ:SDGR).
Aclarion has a consensus price target of $7.50.
The stock price for Aclarion (NASDAQ: ACON) is $1.92 last updated October 23, 2026 at 6:01 PM EDT.
There are no upcoming dividends for Aclarion.
Aclarion does not have any upcoming earnings scheduled.
There is no upcoming split for Aclarion.
Aclarion is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first...